| - GRCh37:
- Chr19:11217369
- GRCh38:
- Chr19:11106693
| LDLR | | Hypercholesterolemia, familial, 1 | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224315-11224316
- GRCh38:
- Chr19:11113639-11113640
| LDLR | Y321fs, Y362fs, Y448fs, Y489fs | Hypercholesterolemia, familial, 1 | Likely pathogenic (Feb 28, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11215979
- GRCh38:
- Chr19:11105303
| LDLR | D133Y, D92Y | Hypercholesterolemia, familial, 1 | Likely pathogenic (Feb 14, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11210948
- GRCh38:
- Chr19:11100272
| LDLR | C125*, C39* | Hypercholesterolemia, familial, 1 | Likely pathogenic (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11216076
- GRCh38:
- Chr19:11105400
| LDLR | W124*, W165* | Hypercholesterolemia, familial, 1 | Likely pathogenic (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11211007
- GRCh38:
- Chr19:11100331
| LDLR | S145F, S59F | Hypercholesterolemia, familial, 1 | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11227622-11227623
- GRCh38:
- Chr19:11116946-11116947
| LDLR | L431fs, L472fs, L558fs, L599fs | Hypercholesterolemia, familial, 1 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr19:11227648
- GRCh38:
- Chr19:11116972
| LDLR | H439D, H480D, H566D, H607D | Hypercholesterolemia, familial, 1 | Pathogenic (Sep 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11213519-11256864
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Nov 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224011-11224012
- GRCh38:
- Chr19:11113335-11113336
| LDLR | D288fs, D374fs, D415fs, D247fs | Cardiovascular phenotype, Hypercholesterolemia, familial, 1 | Pathogenic (Oct 19, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11216262
- GRCh38:
- Chr19:11105586
| LDLR | D186G, D227G | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr19:11222188
- GRCh38:
- Chr19:11111512
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11200038-11213339
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Mar 25, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr19:11222190-11227674
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Jul 1, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr19:11210937
- GRCh38:
- Chr19:11100261
| LDLR | D36Y | Hypercholesterolemia, familial, 1 | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| | LDLR | G206fs, G247fs, G333fs, G374fs | Hypercholesterolemia, familial, 1 | Pathogenic (Jun 26, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr19:11210881
- GRCh38:
- Chr19:11100205
| LDLR | | Familial hypercholesterolemia, Cardiovascular phenotype, Hypercholesterolemia, familial, 1
| Likely benign (Oct 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11240239
- GRCh38:
- Chr19:11129563
| LDLR | R773W, R636W, R646W, R814W | Cardiovascular phenotype, Familial hypercholesterolemia, Hypercholesterolemia, familial, 1
| Uncertain significance (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42699970
- GRCh38:
- Chr5:42699868
| GHR | V140F, V162F, V169F | Short stature due to partial GHR deficiency, Hypercholesterolemia, familial, 1, Laron-type isolated somatotropin defect, not provided | Conflicting interpretations of pathogenicity (Oct 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr19:11226791
- GRCh38:
- Chr19:11116115
| LDLR | W368C, W409C, W495C, W536C | Hypercholesterolemia, familial, 1, Familial hypercholesterolemia | Conflicting interpretations of pathogenicity (May 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr19:11226874
- GRCh38:
- Chr19:11116198
| LDLR | N396T, N437T, N523T, N564T | Hypercholesterolemia, familial, 1 | Pathogenic (Feb 15, 2022) | criteria provided, single submitter |
| | LDLR | | Hypercholesterolemia, familial, 1 | Likely pathogenic (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224020
- GRCh38:
- Chr19:11113344
| LDLR | E250G, E291G, E377G, E418G | Hypercholesterolemia, familial, 1 | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11223981
- GRCh38:
- Chr19:11113305
| LDLR | N237I, N278I, N364I, N405I | Hypercholesterolemia, familial, 1 | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11230887-11230888
- GRCh38:
- Chr19:11120211-11120212
| LDLR | F487fs, F528fs, F614fs, F655fs | Hypercholesterolemia, familial, 1 | Likely pathogenic (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11230757
- GRCh38:
- Chr19:11120081
| LDLR | | Hypercholesterolemia, familial, 1 | Likely pathogenic (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11227533
- GRCh38:
- Chr19:11116857
| LDLR | | Hypercholesterolemia, familial, 1 | Likely pathogenic (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224439
- GRCh38:
- Chr19:11113763
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11215964
- GRCh38:
- Chr19:11105288
| LDLR | C128G, C87G | Hypercholesterolemia, familial, 1 | Pathogenic (Dec 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11231079-11231080
- GRCh38:
- Chr19:11120403-11120404
| LDLR | G507fs, G634fs, G675fs | Hypercholesterolemia, familial, 1 | Pathogenic (Dec 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11215995
- GRCh38:
- Chr19:11105319
| LDLR | S138*, S97* | Hypercholesterolemia, familial, 1 | Pathogenic (Dec 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11227585
- GRCh38:
- Chr19:11116909
| LDLR | S418P, S459P, S545P, S586P | Hypercholesterolemia, familial, 1 | Likely pathogenic (Apr 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11200217
- GRCh38:
- Chr19:11089541
| LDLR, LDLR-AS1 | | Hypercholesterolemia, familial, 1 | Uncertain significance (Apr 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11213513-11223903
| LDLR | | Hypercholesterolemia, familial, 1 | Likely pathogenic (Nov 2, 2021) | criteria provided, single submitter |
| | LDLR | | Hypercholesterolemia, familial, 1 | Uncertain significance (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224322
- GRCh38:
- Chr19:11113646
| LDLR | W322C, W363C, W449C, W490C | Cardiovascular phenotype | Likely pathogenic (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11222307
- GRCh38:
- Chr19:11111631
| LDLR | K225T, K266T, K352T, K393T | Hypercholesterolemia, familial, 1 | Pathogenic (Jul 24, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr19:11217310
- GRCh38:
- Chr19:11106634
| LDLR | C128F, C214F, C255F | Hypercholesterolemia, familial, 1 | Pathogenic (Nov 16, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr19:11217273
- GRCh38:
- Chr19:11106597
| LDLR | C116S, C202S, C243S | not provided | Likely pathogenic (Nov 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11216201
- GRCh38:
- Chr19:11105525
| LDLR | G166C, G207C | Hypercholesterolemia, familial, 1 | Pathogenic (Jan 21, 2007) | no assertion criteria provided |
| - GRCh37:
- Chr19:11216200
- GRCh38:
- Chr19:11105524
| LDLR | S165R, S206R | Hypercholesterolemia, familial, 1 | Pathogenic (Aug 4, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr19:11216188
- GRCh38:
- Chr19:11105512
| LDLR | H162fs, H203fs | Hypercholesterolemia, familial, 1 | Pathogenic (Oct 25, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr19:11215960
- GRCh38:
- Chr19:11105284
| LDLR | F126L, F85L | Hypercholesterolemia, familial, 1 | Pathogenic (Jul 26, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr19:11240286
- GRCh38:
- Chr19:11129610
| LDLR | Q651H, Q661H, Q788H, Q829H | Hypercholesterolemia, familial, 1 | Pathogenic (Jun 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr19:11230902
- GRCh38:
- Chr19:11120226
| LDLR | Q492H, Q533H, Q619H, Q660H | Cardiovascular phenotype | Uncertain significance (Dec 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11227561
- GRCh38:
- Chr19:11116885
| LDLR | V410F, V451F, V537F, V578F | Cardiovascular phenotype, Familial hypercholesterolemia | Uncertain significance (Jan 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11224402
- GRCh38:
- Chr19:11113726
| LDLR | S349F, S390F, S476F, S517F | Hypercholesterolemia, familial, 1 | Pathogenic (Oct 10, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr19:11210933
- GRCh38:
- Chr19:11100257
| LDLR | Q35fs | Hypercholesterolemia, familial, 1 | Pathogenic (Aug 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr19:11215954-11215960
- GRCh38:
- Chr19:11105278-11105284
| LDLR | Q125fs, Q84fs | Hypercholesterolemia, familial, 1 | Likely pathogenic (Oct 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr19:11221454
- GRCh38:
- Chr19:11105168-11105169
| LDLR | | Hypercholesterolemia, familial, 1 | Uncertain significance (Apr 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11211012
- GRCh38:
- Chr19:11100336
| LDLR | E61* | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr19:11221430
- GRCh38:
- Chr19:11110754
| LDLR | A180V, A221V, A307V, A348V | Hypercholesterolemia, familial, 1 | Uncertain significance (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11216064
- GRCh38:
- Chr19:11105388
| LDLR | I120N, I161N | Familial hypercholesterolemia, Hypercholesterolemia, familial, 1 | Conflicting interpretations of pathogenicity (Sep 26, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr19:11213375-11213381
- GRCh38:
- Chr19:11102699-11102705
| LDLR | G76fs | Familial hypercholesterolemia, Hypercholesterolemia, familial, 1 | Pathogenic/Likely pathogenic (Dec 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11241810
- GRCh38:
- Chr19:11131134
| LDLR | | Hypercholesterolemia, familial, 1 | Benign (Jun 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11227097
- GRCh38:
- Chr19:11116421
| LDLR | | Hypercholesterolemia, familial, 1 | Benign (Jun 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11227070
- GRCh38:
- Chr19:11116394
| LDLR | | Hypercholesterolemia, familial, 1 | Benign (Jun 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224491
- GRCh38:
- Chr19:11113815
| LDLR | | Hypercholesterolemia, familial, 1 | Benign (Jun 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224431
- GRCh38:
- Chr19:11113755
| LDLR | V359I, V400I, V486I, V527I | Hypercholesterolemia, familial, 1, Familial hypercholesterolemia | Uncertain significance (Nov 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11226795
- GRCh38:
- Chr19:11116119
| LDLR | T370A, T411A, T497A, T538A | Hypercholesterolemia, familial, 1, Familial hypercholesterolemia | Uncertain significance (Aug 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11238770
- GRCh38:
- Chr19:11128094
| LDLR | | Familial hypercholesterolemia, Hypercholesterolemia, familial, 1 | Likely benign (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11222197-11222198
- GRCh38:
- Chr19:11111521-11111522
| LDLR | C190fs, C231fs, C317fs, C358fs | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11222189
- GRCh38:
- Chr19:11111513
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11240348
- GRCh38:
- Chr19:11129672
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| | LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| | LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| | LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| | LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| | LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| | LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11230865-11230866
- GRCh38:
- Chr19:11120189-11120190
| LDLR | S480fs, S521fs, S607fs, S648fs | Hypercholesterolemia, familial, 1 | Pathogenic (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11210933
- GRCh38:
- Chr19:11100257
| LDLR | C34W | Hypercholesterolemia, familial, 1 | Likely pathogenic (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11226869
- GRCh38:
- Chr19:11116193
| LDLR | W394C, W435C, W521C, W562C | Hypercholesterolemia, familial, 1 | Likely pathogenic (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224098
- GRCh38:
- Chr19:11113422
| LDLR | S276F, S317F, S403F, S444F | Hypercholesterolemia, familial, 1 | Likely pathogenic (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224044
- GRCh38:
- Chr19:11113368
| LDLR | L258R, L299R, L385R, L426R | Cardiovascular phenotype, not provided, Familial hypercholesterolemia, Hypercholesterolemia, familial, 1 | Conflicting interpretations of pathogenicity (May 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr19:11233850-11234020
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Nov 21, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11221328-11227674
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Aug 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11217241-11217363
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Sep 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11213340-11217363
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Dec 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11210899-11218190
| LDLR | | Hypercholesterolemia, familial, 1 | Pathogenic (Apr 25, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11227553
- GRCh38:
- Chr19:11116877
| LDLR | L407P, L448P, L534P, L575P | Familial hypercholesterolemia, Cardiovascular phenotype, Hypercholesterolemia, familial, 1
| Conflicting interpretations of pathogenicity (Mar 13, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr8:27364441
- GRCh38:
- Chr8:27506924
| EPHX2 | G144A, G131A, G197A | Hypercholesterolemia, familial, 1 | Uncertain significance (Jan 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11213352
- GRCh38:
- Chr19:11102676
| LDLR | C68F | Hypercholesterolemia, familial, 1, Familial hypercholesterolemia | Uncertain significance (Apr 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11221363
- GRCh38:
- Chr19:11110687
| LDLR | S158P, S199P, S285P, S326P | Hypercholesterolemia, familial, 1 | Uncertain significance (Feb 14, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr19:11224094
- GRCh38:
- Chr19:11113418
| LDLR | W275R, W316R, W402R, W443R | Hypercholesterolemia, familial, 1, Familial hypercholesterolemia | Pathogenic/Likely pathogenic (Aug 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11210970
- GRCh38:
- Chr19:11100294
| LDLR | D47Y | Hypercholesterolemia, familial, 1 | Uncertain significance (Mar 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr19:11224288
- GRCh38:
- Chr19:11113612
| LDLR | L311Q, L352Q, L438Q, L479Q | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr19:11224021-11224022
- GRCh38:
- Chr19:11113345-11113346
| LDLR | Y251fs, Y292fs, Y378fs, Y419fs | Cardiovascular phenotype | Pathogenic (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11221401
- GRCh38:
- Chr19:11110725
| LDLR | C170W, C211W, C297W, C338W | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr19:11221441-11221443
- GRCh38:
- Chr19:11110765-11110767
| LDLR | C184del, C225del, C311del, C352del | Hypercholesterolemia, familial, 1 | Likely pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11230883
- GRCh38:
- Chr19:11120207
| LDLR | L486P, L527P, L613P, L654P | Cardiovascular phenotype, Familial hypercholesterolemia | Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:21232818
- GRCh38:
- Chr2:21009946
| APOB | E2308K | Hypercholesterolemia, familial, 1 | Uncertain significance (Jan 24, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21236321
- GRCh38:
- Chr2:21013449
| APOB | D1309E | Cardiovascular phenotype, Hypercholesterolemia, familial, 1 | Uncertain significance (Aug 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21232591-21232592
- GRCh38:
- Chr2:21009719-21009720
| APOB | Q2383fs | Hypercholesterolemia, familial, 1 | Likely pathogenic (Sep 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11218158
- GRCh38:
- Chr19:11107482
| LDLR | D136fs, D177fs, D263fs, D304fs | Hypercholesterolemia, familial, 1 | Pathogenic (May 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11218100-11218102
- GRCh38:
- Chr19:11107424-11107426
| LDLR | C116del, C157del, C243del, C284del | Hypercholesterolemia, familial, 1 | Likely pathogenic (Jun 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11218095
- GRCh38:
- Chr19:11107419
| LDLR | F114C, F155C, F241C, F282C | Hypercholesterolemia, familial, 1 | Uncertain significance (Jun 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11218094
- GRCh38:
- Chr19:11107418
| LDLR | F114L, F155L, F241L, F282L | Hypercholesterolemia, familial, 1 | Uncertain significance (Jun 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11218093-11218094
- GRCh38:
- Chr19:11107417-11107418
| LDLR | F114fs, F155fs, F241fs, F282fs | Hypercholesterolemia, familial, 1 | Pathogenic (Jun 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11224354
- GRCh38:
- Chr19:11113678
| LDLR | A333G, A374G, A460G, A501G | Hypercholesterolemia, familial, 1 | Uncertain significance (Dec 6, 2018) | criteria provided, single submitter |